Go Back

AliveCor Launches Third Generation Heart Monitor Advancing the Future of Heart Health

SAN FRANCISCO, Calif. December 18, 2014

New Compact Medical Grade Mobile ECG Device Offered at Only $74.99

AliveCor, Inc. announced today the launch of its third generation AliveCor® Heart Monitor, a step forward for anyone concerned with their own heart health or that of their family members. Now, at an introductory price of $74.99 users have the ability to identify and manage heart conditions with an FDA-cleared electrocardiogram (ECG) monitor, anywhere and at anytime. The third generation device is now 50% thinner and 40% lighter and was designed from first-hand customer feedback and in collaboration with global design firm IDEO.

Atrial fibrillation (AF) continues to be the most common heart rhythm disturbance, affecting more than 140 million people worldwide. AliveCor is focused on helping those with diagnosed and undiagnosed heart conditions, by providing patients and caregivers a tool to detect and manage heart conditions.

Today, users of the AliveCor Heart Monitor are recording 130,000 ECGs per month and actively tracking over 10,000 symptoms, medications and activities that may be affecting their health. In the first two months since the AF Detector algorithm was launched, AliveCor has detected more than 20,000 incidents of AF in more than 30% of users recording ECGs. Detecting AF is the first step to initiating a treatment plan to reduce stroke risk, as people with AF are five times more likely to suffer a stroke than those without the condition. Additionally, users continue to engage with the product over time: 70% are regularly using the device after six months*.

“I used to get frustrated when I would experience what I thought was an AF episode but couldn’t get to the doctor’s office fast enough to confirm my instincts,” said Terry Reilly, AliveCor Patient since 2012. “With the AliveCor Heart Monitor, I am relieved to have an easy-to-use tool at my fingertips that can instantly detect my AF episodes when they happen.”

“The AliveCor Heart Monitor leads to results that I can use to manage my patients remotely, a trend that is here to stay,” said Jeffrey Olgin, MD, chief, Division of Cardiology Co-Director, Heart and Vascular Center at the University of California San Francisco. “Seeing my patients’ ECG results in real-time is the next best thing to having them in my office when the event takes place. I’m pleased to see that AliveCor is lowering the price so more of my patients can afford it.”

“Big data and personalized medicine are revolutionizing the delivery of care and have the potential to disrupt the way we think about healthcare. We are excited to be on the forefront of helping patients manage their cardiac health,” said Euan Thomson, president and chief executive officer at AliveCor. “The newest generation of the Heart Monitor confirms AliveCor’s ongoing commitment to help stop the unnecessary loss of life and healthcare costs driven by undiagnosed and under-managed heart arrhythmias that lead to potentially life-threatening conditions like strokes.”

The third generation AliveCor Heart Monitor, made in the U.S., and compatible with the free AliveECG app, is available for pre-order now at store.alivecor.com. Beginning in January 2015 it will be available on Amazon and through AliveCor’s collaboration with Omron Healthcare, a leading manufacturer of home blood pressure monitors. Devices will begin shipping January 5.

The AliveCor Heart Monitor is intended to record, store and transfer single-channel ECG rhythms. The AliveCor Heart Monitor also displays ECG rhythms and detects the presence of atrial fibrillation (when prescribed or used under the care of a physician). The AliveCor Heart Monitor is intended for use by healthcare professionals, patients with known or suspected heart conditions and health conscious individuals. The device has not been tested and it is not intended for pediatric use. The AliveCor Heart Monitor is compatible with all iOS models and most Android mobile devices. With secure storage in the cloud, users have the ability to access their data confidentially anytime, anywhere.

About AliveCor, Inc.

AliveCor Inc. is a global innovator in mobile technology for heart health. AliveCor works with health systems to help identify patients with undiagnosed heart conditions before potentially life-threatening conditions, like stroke, can occur. AliveCor helps diagnosed patients work with their physician to monitor, track and manage their condition in new ways. AliveCor is a privately-held company headquartered in San Francisco, Calif. For more information, please visit www.alivecor.com.

AliveCor is a trademark of AliveCor, Inc., registered in the U.S. and other countries. iPhone® is a trademark of Apple Inc., registered in the U.S. and other countries. Android is a trademark of Google Inc., registered in the U.S. and other countries.

Most Recent

June 5, 2024

AliveCor’s AI-backed ECG Offerings Featured in New Film Series on Innovative Technologies Presented by the Consumer Technology Association

Read More

November 10, 2023

AliveCor Appoints Michael Rolla as Chief Revenue Officer, Enterprise

Read More

September 27, 2023

AliveCor's KardiaMobile® 6L Becomes First Personal ECG Device Recommended for Use in Psychiatric Services in England and Wales

Read More

Let's transform cardiovascular care together

If you are an employer or payer looking for a comprehensive heart health enterprise solution, contact us.